2022 annual financial data
Royalty Pharma 2022 Net margin
Direct answer
Net margin was 1.91%.
Operating income was 307,065,000 USD and net income was 42,832,000 USD.
Operating cash flow was 2,143,980,000 USD.
Get free Royalty Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,237,215,000 USD
- Operating income
- 307,065,000 USD
- Net income
- 42,832,000 USD
- Operating cash flow
- 2,143,980,000 USD